TalkMed
65 Equity Partners-backed Tamarind Health offers to privatize Singapore healthcare firm TalkMed
Tamarind Health, a Singapore-based pan-Asian oncology-focused group backed by investors including Temasek unit 65 Equity Partners, is offering S$0.456 ($0.34) per share to privatize cancer specialist TalkMed Group.
